PHOSPHOLIPON AS A BINDER IN THE FORMULATION OF 4- ACETOMIDOPHENOL TABLETS

Abstract

 ABSTRACT Pharmaceutical manufacturing inform of liposomal delivery has one of the most important approaches to improve the cellular uptake and subsequent bioavailability of drugs and as such phospholipon was chosen as a binder and studied for its effectiveness by comparing with microcrystalline cellulose and corn starch using wet granulation method. Wet granulation method using phospholipon, corn starch and microcrystalline cellulose as a binder was employed. The compressed tablets were evaluated for the following physicochemical characteristics; general appearance, weight variation, friability, hardness, disintegration and in vitro drug release studies. The release pattern of 1% dispersion of phospholipon in water has met the USP specification, in which more than 80 % of paracetamol tablet was released at 30 minutes. The release pattern of the drug was observed to be time dependent at the duration of time used. In addition, the amount of drug released by phospholipon and corn starch at 60 minutes interval was greater than 100%. The tablets obtained in this study have an approximate average weight which is within the limit of the percentage deviation allowed by USP. The tablets showed a slight variation in diameter and thickness which is within the BP limits and hence negligible. In the present study, the observed hardness for phospholipon and MCC were within the USP specification (4 to 8 kgF), whereas for corn starch, the value were above the USP specification. The percentage friability of the MCC was similar to that of the phospholipon, whereas for corn starch, the value was lower. The disintegration time of phospholipon was found to be higher than the two formulations. The binding capacity of phospholipon at low concentration for drug delivery especially in the formulation of paracetamol tablets was assessed and found to be better than microcrystalline cellulose and corn starch. This amply justifies the current use of phospholipon as a binder in many pharmaceutical formulations. Keywords: Phospholipon, 4-acetomidophenol, Binder, Tablet.

Authors and Affiliations

Galadima HI1* , Mbah CC1 , Emenike IV2 , Moh’d AS3 , Timothy SY4

Keywords

Related Articles

 ORAL MANIFESTATIONS OF DENGUE HAEMORRHAGIC FEVER: A REVIEW

 ABSTRACT Dengue viral infection is a cause of considerable morbidity and mortality and may be associated with a variety of mucocutaneous manifestations that may provide important early clues to the diagnosis of t...

 DEVELOPMENT AND VALIDATION OF NEWER ANALYTICAL METHOD FOR THE ESTIMATION OF NEVIRAPINE IN BULK AND IN TABLET DOSAGE FORM BY RP – HPLC METHOD

 ABSTRACT A simple, sensitive, specific RP-HPLC method was developed for the estimation of Nevirapine in bulk and pharmaceutical formulation. This method was based on HPLC separation of the drug in reverse phase m...

 COMPARATIVE EVALUATION OF A COLORIMETRIC MICROTITRE PLATE ASSAY IN DETERMINING THE MINIMUM INHIBITION CONCENTRATION OF ANTIMICROBIALS AND PRESERVATIVES IN COSMETIC AND TOILETRY FORMULATIONS

 ABSTRACT Preservatives and antimicrobials are commonly used in cosmetic and toiletry products in order to increase the shelf life of the products. Thus the effective concentration of these chemical agents is one...

 SOLID LIPID NANOPARTICLES: FOR ENHANCEMENT OF ORAL BIOAVAILABILITY

 Solid lipid nanoparticles are emerging as alternative carriers to colloidal systems for controlled and targeted drug delivery. SLNs combine the advantages of different colloidal carriers, like emulsions, liposome’s...

 TABLETING PROPERTIES OF THERMALLY ACTIVATED COW BONE POWDER IN HIGH DOSE FORMULATION

 ABSTRACT Activated cow bone powder was evaluated and found suitable as a diluent in the formulation of low and high dose drugs. This study was conducted in order to compare the diluent properties of dicalcium pho...

Download PDF file
  • EP ID EP128357
  • DOI -
  • Views 75
  • Downloads 0

How To Cite

Galadima HI1*, Mbah CC1, Emenike IV2, Moh’d AS3, Timothy SY4 (2016).  PHOSPHOLIPON AS A BINDER IN THE FORMULATION OF 4- ACETOMIDOPHENOL TABLETS. International Journal of Pharmaceutical Development & Technology, 6(1), 47-52. https://europub.co.uk/articles/-A-128357